Cargando…
Osteonecrosis of the Jaws in Patient Received Bisphosphonates and Sunitinib Separately: A Case Report
Recently published reports have suggested that antiangiogenic drugs such as sunitinib could potentiate the osteonecrosis of the jaw (ONJ) induced by bisphosphonates (BPs) and even induce this adverse effect per se. We reported a case of ONJ with renal cell carcinoma under sunitinib medication and hi...
Autores principales: | Ashrafi, Farzaneh, Derakhshandeh, Ali, Movahedian, Bijan, Moghaddas, Azadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632940/ https://www.ncbi.nlm.nih.gov/pubmed/29026845 http://dx.doi.org/10.4103/jrpp.JRPP_17_36 |
Ejemplares similares
-
Bisphosphonate related osteonecrosis of the jaws: report of two cases
por: Han, Jin-Woo
Publicado: (2011) -
Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012) -
Bisphosphonates and Osteonecrosis of the Jaw: A Case Report
por: Reiriz, André Borba, et al.
Publicado: (2008) -
Osteonecrosis of the jaws in patients treated with bisphosphonates
por: Ata-Ali, Fadi, et al.
Publicado: (2012) -
Refinements in the reconstruction of bisphosphonate-related osteonecrosis of the jaw
por: Maeda, Taku, et al.
Publicado: (2022)